ICON PLC Q1 Revenue, EPS, and EBITDA Beat Estimates, Reaffirming Guidance
ICLR has more than doubled off its 52-week low of $66.57.
Summary
ICON PLC reported Q1 results that surpassed analyst expectations across key metrics, including revenue of $2.03 billion, adjusted EPS of $2.50, and adjusted EBITDA of $317.73 million. This performance, driven by strong commercial momentum and new partnerships, comes after a challenging period for the company. The positive earnings follow a series of SEC filings in late May detailing significant financial restatements, internal control failures, and a Nasdaq non-compliance notice. The beats and reaffirmed full-year guidance suggest the company is making strides towards operational and financial stabilization, which could help rebuild investor confidence.
At the time of this announcement, ICLR was trading at $147.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.9B. The 52-week trading range was $66.57 to $211.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.